© BIOTECanada 2011 A “Made in Canada” Success Story: Flow-through Shares Wednesday, October 5 th, 2011 Anthony Giovinazzo, President & CEO, Cynapsus Therapeutics.

Slides:



Advertisements
Similar presentations
Presentation to Venture Association of New Jersey 3/16/04.
Advertisements

The Canadian Experience with Income Trusts. Outline What are income trusts? Tax policy implications Experience in selected countries Revenue implications.
Chapter 13: Investment Fundamentals and Portfolio Management
 $2 000 billion: the total value of the real estate assets that should be disposed of by 58 European banks within 2 years, according to the IMF. EMBA.
Bootstrapping and Financing the closely held company
TAX ISSUES FOR INVESTORS & TRADERS Stacy A. Sand, CPA TAX (8829)
Copyright © 2006 Pearson Education Canada Fiscal Policy 24 CHAPTER.
Chapter 17 1 Copyright © 2008 by Nelson, a division of Thomson Canada Limited Chapter Managing the Firm’s Finances Prepared by Norm Althouse University.
Annual Report 2003 Bank van de Nederlandse Antillen Willemstad, July 5, 2004.
Global Software II Introduction Paving the Way to the US Market For Finnish Software Companies Copyright Global Software II 2002.
Chapter 9 – Incremental Cash Flow  Learning Objectives  Understand the importance of cash flow  Calculate the operating cash flow  Produce a Sources.
R&D Tax credits An overview of the SR&ED Program.
Chapter 10 Incremental Cash Flow  Three Financial Statements  Fundamental Accounting Relationship  Cash Flow Identity to Sources and Uses  Estimating.
June 1, 2010 Commercial Real Estate Fundamentals.
“Real Estate Principles for the New Economy”: Norman G. Miller and David M. Geltner Chapter 11 Introduction to Investment Concepts.
© BIOTECanada 2010 Industry Comparison by GDP and Percentage of the Economy Note: Data based on preliminary 2009 GDP figures. Sources: Source Data - Statistics.
How to Finance Affordable Housing with Low Income Housing Tax Credits July 10, 2007.
Ch. 2 Financial statement, Taxes and Cash flows. 1. Balance sheet Summarizing what a firm owns (assets) and what a firm owes (liabilities) Asset = Liability.
Michal Bodlák. Definition  An investment bank is a financial institution that assists: individuals, corporations and governments companies involved in.
1 Energy Company Valuations “It’s all in there!” Georgia State Economic Forecasting Conference May 25, 2005 Richard T. O’Brien Executive Vice President.
The Canadian Chamber of Commerce Canada’s Opportunities and Barriers for Success May 12, 2011 Toronto, Ontario Chris Gray Director, Innovation Policy
Chevron Greg Hines ACG Executive Summary Chevron has had a great year, they have increased their sales greatly from the previous year. They are.
1 CVCA presentation Innovation & Job Creation August 2010.
Investment Basics Clench Fraud Trust Investment Workshop October 24, 2011 Jeff Frketich, CFA.
Financial Statements, Cash Flow, and Taxes  Key Financial Statements  Balance Sheet  Income Statement  Statement of Stockholders’ Equity  Statement.
Chapter 1 The Financial Environment © 2003 John Wiley and Sons.
Hospital Corporation of America Rovi Das ACG
© 2008 Thomson South-Western CHAPTER 12 INVESTING IN STOCKS AND BONDS.
2-0 McGraw-Hill/Irwin Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved. Financial Statements and Cash Flow Chapter 2.
Venturesome – social purpose finance Paul Cheng Investment Manager, Venturesome.
Steve Paulone Facilitator Financial Management Decisions The financial manager is concerned with three primary categories of financial decisions:  1.Capital.
2Q | 2011 Guide to the Markets As of March 31, 2011.
© 2005 by Center for Energy Economics, Bureau of Economic Geology, The University of Texas at Austin. All rights reserved. 1 Energy Finance Considerations.
© 2013 Cengage Learning. All Rights Reserved. May not be scanned, copied, or duplicated, or posted to a publicly accessible website, in whole or in part.
CITGO Petroleum Corporation Sheryll Dean ACG2021 Section 0H1 & 008
Estimation of the value of unquoted shares of enterprises in the public sector OECD Working Party on Financial Statistics 2008 Paris Paper prepared by.
Slide 1-1 Chapter 1 Introduction. Slide 1-2 Areas of Opportunity in Finance Financial Services: –Banking –Personal financial planning –Investments –Real.
Today's Investment, Tomorrow's Return - A Catalyst for Resurgence Annual Conference November 18, 2003 Terry Matthews Chairman & CEO March Networks Chairman.
Saskatchewan Assessment Appraisers’ Association September 24, 2015.
FUNDAMENTALS OF CORPORATE FINANCE MGF301 Fall 1998 Vigdis Boasson SUNY at Buffalo
Multinational business
NovusFolium Venture Partners Bridging Innovation to Markets Prospective Investment Opportunity.
INVESTMENT ANALYSIS & PORTFOLIO THEORY. Background Reasons for improvements in standards of living Major elements of businesses Human Capital Financial.
0 Chapter 2 Financial Statements, Taxes, and Cash Flow.
Needles Powers Principles of Financial Accounting 12e The Statement of Cash Flows 15 C H A P T E R ©human/iStockphoto.
Overview of Financial Management. OVERVIEW OF FINANCIAL MANAGEMENT The Corporation Life Cycle Value Creation & Maximization Financial Institutions & Process.
©2002 Prentice Hall Business Publishing, Introduction to Management Accounting 12/e, Horngren/Sundem/Stratton Chapter 17 Understanding Corporate.
Chapter 1, Fundamentals by Ross et. al notes by A.P. Palasvirta, Ph.D.
CHAPTER 12: INVESTING IN STOCKS AND BONDS
1 Generations Bancorp. Inc.. 2 Executive Management Gregory P. Kolton, Chairman, President, CEO 35 years of banking experience President/CEO of CIB Marine.
Financial Markets, Instruments, and Market Makers Chapter 3 © 2003 South-Western/Thomson Learning.
Merrill Lynch Matt Western ACG2021 Section 002. Executive Summary Overall Merrill Lynch had a great year in They increased their revenues 11% from.
Financial Management and the Securities Market 12 Chapter © 2004 by Nelson, a division of Thomson Canada Limited.
An Overview of the Financial System chapter 2 1. Function of Financial Markets Lenders-Savers (+) Households Firms Government Foreigners Financial Markets.
Chapter © 2008 McGraw-Hill Ryerson  Financial Statements, Cash Flow, and Taxes Prepared by Ernest Biktimirov, Brock University.
The Impacts of Government Borrowing 1. Government Borrowing Affects Investment and the Trade Balance.
 Emerging Markets. How to invest  ETFs  Mutual Funds  Index Funds.
IPSAS I6: INVESTMENT PROPERTY Presented by: Georgina Muchai Date: 19/8/2015 A closer look 1.
3.1 SOURCES OF FINANCE Unit 3 – Accounts & Finance.
1 Chapter 20 Bank Performance Financial Markets and Institutions, 7e, Jeff Madura Copyright ©2006 by South-Western, a division of Thomson Learning. All.
The basics of mutual fund investing Delivered by:.
ESNA Economic Outlook 2016: Alberta’s Fiscal and Environmental Challenges “It could be worse…..” Mike Percy Ph.D. December 3,
Role of Financial Markets and Institutions
THE GROSS RECEIPTS TAX AND ITS IMPACT ON BUSINESS
4. Mutual Funds, Investment Dealers, and Other FIs
2008 Canadian Energy Survey* Survey of 2007 Results
Corporate Finance John Collins.
Accessing Capital in Small Communities
Professor Chris droussiotis
Presentation transcript:

© BIOTECanada 2011 A “Made in Canada” Success Story: Flow-through Shares Wednesday, October 5 th, 2011 Anthony Giovinazzo, President & CEO, Cynapsus Therapeutics Chair, Emerging Companies Advisory Board Gibril Muddei, Manager, Policy & Research, BIOTECanada

Agenda © BIOTECanada Introduction – 5 min 2.The Risk Capital Gap – 5 min 3.Flow-through Shares “101” – 10 min 4.Industry Proposal – 15 min 5.National Advocacy – 5 min 6.Discussion/Questions – 15 min

Introduction Industry Overview: 600+ core biotech companies 90%+ of companies are pre-commercial “junior biotechs” 300+ bio-therapeutic drugs in development R&D expenditures of $1.7+ billion yearly 11% of all business-sector R&D in Canada is performed by biotech companies © BIOTECanada 2011

Introduction (cont’d) Note: Data based on preliminary 2009 GDP figures. Sources: Source Data - Statistics Canada, CANSIM Table Methodology - Industrial Biotechnology. December 1, 2008, 4(4): doi: /ind Economic Size of Canada’s Leading Industries: © BIOTECanada 2011

The Risk Capital Gap The innovation is here, but the risk capital required to sustain R&D in the long-run is lacking. Canada’s biotechnology industry requires $1 - $1.5 billion annually to sustain itself. This is capital from all sources: Private equity and venture capital Public markets Commercial banks Governments Sources: Biotech 2010 Life Sciences: Adapting for Success, Burrill & Company, BIOTECanada Research Services © BIOTECanada 2011

The Risk Capital Gap (cont’d) © BIOTECanada 2011 Source: Thomson Reuters, Canada’s Venture Capital Market in Q $ CAD (millions) Future of Canada’s VC Market: New Capital Commitments

The Risk Capital Gap (cont’d) “R&D expenditures and venture capital are among the first to be cut during recessions,” OECD In the case of Canada’s biotechnology industry, since 2007: venture capital has fallen by 60%; one company (Ecosynthetix) has gone public; and SR&ED qualifying R&D, for surviving companies, has fallen by 35%. Source: OECD Science, Technology and Industry Scoreboard 2009

Flow-through Shares 101 © BIOTECanada 2011 A flow-through share is: A type of share allowing corporations to transfer certain expenses to investors. Investors can apply them against their personal or corporate income tax. Corporations are those involved in exploration, production, and processing of: mining; oil and gas; and certain renewable energy.

Flow-through Shares 101 (cont’d) Parameters: Transfer: Companies cannot claim expenses passed onto investors on their books. Exploration & Development: Companies have two years to use the proceeds from issuing FTSs on qualifying expenses within Canada. Premium: Shares are issued at a premium (normally 5-20% above market trading price) on account of the tax benefits. Holding period: Usually, shares must be held for 4 months and can last up to 24 months. Adjusted cost base: Value of shares are set to 0; capital gains tax is applied on total value of shares realized, even if at a loss. © BIOTECanada 2011

Flow-through Shares 101 (cont’d) Example - $100 raised via FTS: Company’s Perspective: Transaction Costs: $6 representing/underwriting fees Net Proceeds: $94 would be spent company Investor’s Perspective: Benefit: $45 investor tax deduction at 45% marginal tax rate Net Outlay: $55 represents “dollars at risk” Government Perspective: Cost: $45 investor deduction Direct Tax Benefit: $18 (40% of cost recouped as a result of incremental capital gains) Net Outlay: $27 ($45 – $18) © BIOTECanada 2011 SUMMARY: $1 in foregone revenue to Treasury creates $3.5 in new risk capital that must be spent in Canada.

Flow-through Shares 101 (cont’d) Introduction of 15% Mineral Exploration Tax Credit Introduction of flow-through deductions against other income Introduction of look-back rule and expansion of flow-through shares to renewable energy sector (millions) © BIOTECanada 2011 Economic recession starting with stock market collapse “Black Monday” October 1987 Mineral and precious metal commodity price slowdown Sub-prime mortgage crisis and global economic recession Junior Mining: Source: Sources: Natural Resources Canada, Gamah International

Flow-through Shares 101 (cont’d) Department of Finance (1994) found: FTS accounted average of 60% of all funding for mining exploration between 1987 to 1991; each dollar of federal tax expenditure resulted in incremental expenditures of on average $3 in mining exploration and $2 in petroleum exploration; and one dollar of tax expenditure resulted in $2.6 of new (incremental) exploration spending (multiplier appears to be the same for period ). © BIOTECanada 2011

Industry Proposal © BIOTECanada 2011 Business CharacteristicsJunior Biotechnology Length of Development Cycle Up to 15 years Capital Needs Up to $1.5 billion Risk Profile High-risk, high-failure rates Operating Losses Carry-forward during long development cycle Capital Structure Equity financing; minimal leverage Use of Capital Research and development Development Outcome Intellectual property

© BIOTECanada 2010 Industry Proposal (cont’d) Striking similarities between junior mining companies and or “ junior ” biotechs:  No commercialised products/services; little or no revenue generation  Long development cycles  Capital intensive; operate on a burn rate  Experience difficulty raising capital  Highly sensitive to economic swings  Valuation based on potential for discovery and commercialisation  Volatile cash positions  Raise money by issuing shares (raising debt capital is not a consideration for low operating cash flow companies) Bottom line: BOTH ARE EXTREMELY RISKY TO INVESTORS

Industry Proposal (cont’d) Summary Details: Proposed Eligibility Criteria Eligible Corporations Eligible Investors Eligible Expenditures Eligible Shares Type of Investments Tax Deduction Biotechnology companies Individuals, corporations, trusts SR&ED eligible expenses Regular common shares Direct and portfolio investments 100% of investment Definition exists in Ontario legislation Identical to existing FTS structure Based on definition of SR&ED in legislation Identical to existing FTS structure

Industry Proposal (cont’d) © BIOTECanada 2011 Direct Investment Model: Public Corporations Portfolio Investment Model: Private Corporations

Industry Proposal (cont’d) Economic Impact Analysis: Source: PricewaterhouseCoopers LLP, Economic Impact of Flow-through Shares in Biotechnology Industry

Industry Proposal (cont’d) Summary Administration through existing tax structure (FTS & SR&ED). Principal beneficiaries of FTS would junior tech companies who can obtain funds for R&D, partly in exchange for tax deductions that they would not be able to use for years on end. R&D is restricted to Canada. Investment in SR&ED qualifying activities alone provides a net economic benefit. Full alignment with public policy to support technology commercialization and spur business-sector R&D. Direct costs to government are modest. © BIOTECanada 2011

National Advocacy Biotech/Life Sciences Executives Affiliate Organizations/Associations Investment Community Economic Development Agencies Academia & Tech Transfer Offices Knowledge and Opinion Leaders Federal/provincial elected officials and senior public servants. © BIOTECanada 2011

National Advocacy (cont’d) What are we seeking from the C11? 1.Moral support. 2.Development of policy statement from economic development perspective and subsequent sign-off. 3.Letter of support from C11 to key provincial/federal officials. 4.Presence in key meetings at the provincial government level. 5.Communication with colleagues in your industry. © BIOTECanada 2011

QUESTIONS? © BIOTECanada 2011